Cytokinetics, Incorporated (CYTK) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Cytokinetics (CYTK) Q1 2026: myCORSO Launch Drives $4.8M Debut as HCM Pipeline Expands
May 06, 2026
-
CYTK Q4 2025: MyCORSO Launch Activates 700+ REMS-Certified HCPs, Setting Up Commercial Inflection
February 26, 2026
-
Cytokinetics (CYTK) Q4 2025: MyCORSO Launch Engages 700+ HCPs, Setting Stage for Global Uptake
February 25, 2026
-
Cytokinetics (CYTK) Q3 2025: $1.25B Cash Bolsters Aficampten Launch Readiness
November 06, 2025
-
Cytokinetics (CYTK) Q2 2025: R&D Spend Rises 41% as Affy-Campten Nears Regulatory Decision
August 08, 2025
-
Cytokinetics (CYTK) Q1 2025: $132M Cash Burn Sets Stage for Aficampten Launch Amid REMS Delay
July 06, 2025